This educational program consists of three presentations on LDL-c management.

This course consists of the following:

• Changing paradigms in LDL-c reduction - Prof. Kausik Ray, MD - London, UK
• Targeting the PCSK9 pathway: where do novel therapies fit in? - Ann Marie Navar, MD, PhD - Dallas, TX, USA
• Addressing the unmet needs in LDL-c lowering; what can we expect? - Prof. John Kastelein, MD, PhD - Amsterdam, the Netherlands

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Name 6 current or evolving therapeutic LDL-c lowering options
• Describe the function of PCSK9 and the mechanism of action of PCSK9-targeted therapies
• Recall why the first trials with CETP inhibitors did not yield beneficial effects

Expert faculty

• Prof. Kausik Ray, MD - London, UK
• Ann Marie Navar, MD, PhD - Dallas, TX, USA
• Prof. John Kastelein, MD, PhD - Amsterdam, the Netherlands

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with hypercholesterolemia.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from Daiichi-Sankyo, New Amsterdam Pharma, Novartis, Sanofi & Ultragenyx..

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.